Alison Siedor

ID: 1b83a05f-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

Commercialization of Ustekinumab and Golimumab Biosimilars

Big Molecule Watch · April 3, 2025

Bio-Thera Solutions Expands Partnership with SteinCares to Market Two Biosimilars in LATAM

Big Molecule Watch · December 19, 2024

Celltrion Launches STEQEYMA (ustekinumab) in Germany and the Netherlands

Big Molecule Watch · November 14, 2024

PTAB Institutes Sarepta’s IPR

Big Molecule Watch · September 6, 2024

Biogen’s TOFIDENCE (tocilizumab) Approved in the EU

Big Molecule Watch · June 28, 2024